India's Most Reputed Pharmaceutical Brands study prepared by BlueBytes in association with TRA Research (both part of the Comniscient Group) has dominated by leading Indian pharma companies. Lupin remained on top in reputation in the pharma segment. Followed by Sun Pharmaceutical with a 52 per cent lower Brand Rep Score and Cipla is at third position with a Brand Rep Score 28 per cent behind the previous rank. Dr Reddy's Laboratories ranked as fourth Most Reputed Pharma Brand, behind 71 per cent in terms of Brand Rep Points. Among global brands GSK leads the way followed by Pfizer and Abbott.

Pooja Kaura, chief spokesperson for India's Most Reputed Brands, said, “India's reputation as the largest producer of generic drugs in the world has become vulnerable in light of the changing patent regime in the country. Reports say that by 2020, India is likely to be among the top three pharmaceutical markets by incremental growth and sixth largest market globally in absolute size. Reputation is defined as a measure of the effectiveness of transmitted belief about attitudes showcasing Respect – and our report measures the consumer Respect for a brand and also its transmission by measuring the media quotient. Given the importance of this sector for the economy and to the public, brands should concentrate on building and maintaining their reputation to stay ahead in the changing world.”

The study conducted by BlueBytes analyzing news of 58 pharma brands in all the major English and Hindi print media (newspapers and magazines) across 9 cities as a representative of the news across all media. A total of 24,414 articles pharma news were analyzed between July 15, 2015, and July 16, 2016. In addition to news analysis, the consumer's perception was also studied and this part of the analysis was contributed by TRA Research, which interviewed 2,500 consumer-influencers on the aspect of respect. The 60-page, soft-bounded report is available for Rs. 999.